Boothbay Fund Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$20.2 - $25.05 $3.07 Million - $3.81 Million
-151,900 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$17.09 - $24.89 $206,789 - $301,169
-12,100 Reduced 7.38%
151,900 $3.61 Million
Q1 2020

May 15, 2020
BUY
$14.45 - $24.69 $2.37 Million - $4.05 Million
164,000 New
164,000 $2.95 Million

Others Institutions Holding SUPN

# of Institutions
255
Shares Held
59.2M
Call Options Held
47.9K
Put Options Held
13.1K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.7B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email